← Evidence map

ArticleJournal for immunotherapy of cancer2022

Correction: Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36096538